Undetected cardiogenic shock in patients with congestive heart failure presenting to the emergency department.
The purpose of this study was to examine the use of lactic acid levels and continuous central venous oxygen saturation (central venous oximetry) to stratify and treat patients with acutely decompensated end-stage chronic congestive heart failure (CHF) presenting to the emergency department. This prospective, convenience, non-outcome study was performed at an urban tertiary care hospital. Patients with end-stage CHF with an ejection fraction <30% presenting in decompensated CHF were eligible for the study. Patients were assessed using the Killip classification and New York Heart Association criteria. After lactic acid levels were obtained, patients were managed according to a standardized protocol guided by central venous oximetry. The patients were divided into high lactic acid (n = 22), low lactic acid (n = 5), and control groups (stable patients presenting to a cardiology clinic, n = 17) for comparison. There was no statistical difference in vital signs, or Killip and New York Heart Association criteria among the 3 groups. Central venous oxygen saturation was significantly lower in the high lactic acid group (32 +/- 12%) than in the normal lactic acid (51 +/- 13%) and control groups (60 +/- 6%) (p < 0.001). After treatment there was a significant decrease in lactic acid (-3.65 +/- 3.65 mM/L) and an increase in central venous oxygen saturation (32 +/- 13%) in the high lactic acid group compared with the normal lactic acid group (p < 0.001). A significant subset of patients with decompensated end-stage CHF present to the emergency department in occult shock and are clinically indistinguishable from patients with mildly decompensated CHF and stable CHF. Once identified, these patients require aggressive alternative management and disposition. Further study is necessary to identify whether this intervention impacts morbidity, mortality, and health care resource consumption.
Ander
D S
DS
Department of Emergency Medicine, Emory University, Atlanta, Georgia 30303, USA.
Jaggi
M
M
Rivers
E
E
Rady
M Y
MY
Levine
T B
TB
Levine
A B
AB
Masura
J
J
Gryzbowski
M
M
D000368:Aged; D016022:Case-Control Studies; D004630:Emergencies; D004638:Emergency Treatment; D006333:Heart Failure / Q000150:complications* / Q000453:epidemiology / Q000628:therapy; D006801:Humans; D019344:Lactic Acid / Q000097:blood; D008875:Middle Aged; D010092:Oximetry; D010100:Oxygen / Q000097:blood; D011446:Prospective Studies; D012770:Shock, Cardiogenic / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy
D019344:Lactic Acid; D010100:Oxygen